Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid TumorsMasayuki Takeda, Kazuto Nishio, Kazuko Sakai et al.|The Oncologist|2020Cited by 95
Targeting of the HER2/HER3 signaling axis overcomes ligand‐mediated resistance to trastuzumab in HER2‐positive breast cancerSatomi Watanabe, Kazuhiko Nakagawa|Cancer Medicine|2019Cited by 74